Genprex, Inc. - Common Stock (NQ:GNPX)

2.680 +0.050 (+1.90%)

Delayed Quote Updated: 11:49 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Genprex, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Upcoming Barcelona Conference

March 13, 2023

Via Investor Brand Network

Genprex’s Gene Therapy: Potential Breakthrough for Diabetes and Lung Cancer

March 09, 2023

Genprex’s Gene Therapy: Potential Breakthrough for Diabetes and Lung Cancer

Via News Direct

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Management to Participate in Two Upcoming Conferences

March 08, 2023

Via Investor Brand Network

S&P 500 Rises Over 0.5%; US Pending Home Sales Increase Sharply ↗

February 27, 2023

U.S. stocks traded higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Monday. The Dow traded up 0.40% to 32,949.23 while the NASDAQ rose 0.93% to 11,500.59. The...

Via Benzinga

Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 27, 2023

Gainers Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 27, 2023

Via Benzinga

Nasdaq Rises 80 Points; TEGNA Shares Plunge ↗

February 27, 2023

U.S. stocks traded higher midway through trading, with the NASDAQ Composite gaining around 80 points on Monday. The Dow traded up 0.15% to 32,867.61 while the NASDAQ rose 0.70% to 11,475.20. The S&P...

Via Benzinga

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $4M Registered Direct Offering

February 27, 2023

Via Investor Brand Network

Why Genprex Shares Are Getting Hammered Today ↗

February 27, 2023

Genprex Inc (NASDAQ: GNPX) shares are trading lower by 19.12% to $1.10 during Monday's pre-market session. The company announced a $4 million registered direct offering with an institutional investor....

Via Benzinga

TDOC Stock Alert: What to Know as SVB Securities Upgrades Teladoc ↗

February 23, 2023

Teladoc (TDOC) stock is on the move Thursday after getting an upgrade from SVB Securities even after a poor earnings report.

Via InvestorPlace

Genprex (GNPX) Stock Moves on Promising Diabetes Treatment Data ↗

February 23, 2023

Genprex (GNPX) stock is on the move Thursday after providing investors with an update on a clinical trial of its diabetes treatment.

Via InvestorPlace

Why Enovix Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

February 23, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 23, 2023

We're starting off the day with a look at all the biggest pre-market stock movers traders need to know about on Thursday!

Via InvestorPlace

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Inks Deal with University of Pittsburgh for Exclusive License to Diabetes Technology

January 05, 2023

Via Investor Brand Network

Topics Intellectual Property

Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023 ↗

January 30, 2023

Via Benzinga

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 04, 2023

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...

Via Benzinga

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Gene Therapy Treatment Data to be Presented at Upcoming International Diabetes Conference

January 04, 2023

Via Investor Brand Network

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures SRC Approval to Advance Acclaim-1 Trial, Licenses Additional Technology from University of Pittsburgh

December 15, 2022

Via Investor Brand Network

Topics Intellectual Property

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present Gene Therapies for Cancer and Diabetes at Upcoming Conference

December 02, 2022

Via Investor Brand Network

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation in Upcoming Investor, Industry Conferences

October 07, 2022

Via Investor Brand Network

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) CFO to Present Pioneering Gene Therapies at Upcoming Conference

September 08, 2022

Via Investor Brand Network

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 19, 2022

Gainers

Via Benzinga

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures New Patent, Critical Protection for REQORSA(TM) Combination Therapy

August 16, 2022

Via Investor Brand Network

Topics Intellectual Property

This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday ↗

August 16, 2022

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 15, 2022

Via Benzinga

Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session ↗

August 15, 2022

Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New...

Via Benzinga

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures SRC Approval to Advance Acclaim-1 Trial to Higher Dose

August 15, 2022

Via Investor Brand Network

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Participate in Next Generation Lipid-Based Nanoparticles Delivery Summit

July 13, 2022

Via Investor Brand Network

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Participate in June Investor Conferences

June 02, 2022

Via Investor Brand Network

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.